IFNG and colitis: Yang et al. reported that IFN-γ-stimulated BM-MSC-EVs target Stat3 mRNA to inhibit Stat3 expression via miR-125a/b, thereby hindering the differentiation of Th17 cells in a colitis mouse model [117].